CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 28, 2008--Alkermes, Inc.
(NASDAQ: ALKS) announced today that its corporate presentation will be
webcast live by Morgan Stanley on Thursday, May 1, 2008 at 1:40 p.m.
EDT. The presentation will be webcast from the Ritz-Carlton, Key
Biscayne, Florida and may be accessed under the investor relation's
tab at www.alkermes.com. The presentation will be archived for 14
Alkermes, Inc., a biotechnology company committed to developing
innovative medicines to improve patients' lives, manufactures
RISPERDAL(R) CONSTA(R) for schizophrenia and developed and
manufactures VIVITROL(R) for alcohol dependence. Alkermes' robust
pipeline includes extended-release injectable, pulmonary and oral
products for the treatment of prevalent, chronic diseases, such as
central nervous system disorders, addiction and diabetes.
Headquartered in Cambridge, Massachusetts, Alkermes has research and
manufacturing facilities in Massachusetts and Ohio.
CONTACT: Alkermes, Inc.
Debra Koufos, 617-583-6220
Associate, Corporate Communications
SOURCE: Alkermes, Inc.